Please Wait.....
Report
Saudi Arabia Cardiovascular Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-06-01 I 81 Pages I Mordor Intelligence
Saudi Arabia Cardiovascular Devices Market Analysis
The Saudi Arabia Cardiovascular Devices Market size is estimated at USD 527.33 million in 2025, and is expected to reach USD 707.40 million by 2030, at a CAGR of 5.21% during the forecast period (2025-2030).
A national pivot toward preventive care, mandatory private insurance, and rapid digitalization under Vision 2030 is moving demand beyond large tertiary hospitals to community clinics and home settings. Therapeutic and surgical products keep their leading revenue position, yet diagnostics and monitoring devices are growing faster as care shifts upstream. Localization incentives are drawing multinational firms into joint ventures with Saudi partners, shrinking import dependence while forcing incumbents to review pricing and channel strategies. Simultaneously, structural heart technologies, AI-enabled imaging, and integrated remote monitoring solutions are opening new revenue pools, even as supply-side bottlenecks such as specialist shortages and multi-layer procurement continue to temper adoption.
Saudi Arabia Cardiovascular Devices Market Trends and Insights
Rising burden of cardiovascular disease
Ischemic heart disease has become the top mortality driver in the Kingdom, with cardiovascular conditions responsible for 42% of all deaths. Diabetes prevalence of 24%, hypertension exceeding 40%, and obesity at 35.4% each accelerate device demand for both interventional and monitoring solutions. The direct economic toll, valued at USD 3.5 billion in 2016, is on track to triple by 2035, prompting hospitals and payers to emphasize early detection. These clinical realities increase uptake of integrated glucose-cardiac monitors and AI-enabled risk stratification tools. Gender gaps in disease expression also present commercial scope for female-specific stent sizes and rhythm devices. Continued epidemiological surveillance keeps pressure on suppliers to broaden product portfolios that can manage comorbid metabolic risk. /
Large-scale Vision 2030 healthcare investment
The 2024 national budget reserved SAR 260 billion (USD 69.3 billion) for health and social development. Five new hospitals with 963 cardiovascular-ready beds will open by 2025, while cluster models integrate peripheral clinics via tele-cardiology networks. These physical and digital expansions accelerate placements of cath-lab imaging, portable ultrasound, and remote patient monitoring kits. Government procurement increasingly embeds local-content clauses, encouraging multinationals to establish technical transfer agreements with Saudi factories. As infrastructure matures, high-acuity centers in Riyadh and Jeddah become referral anchors for complex structural heart and electrophysiology cases.
Fragmented hospital procurement & lengthy SFDA approval cycles
Separate supply chains for Ministry hospitals, military facilities, universities, and private networks mean vendors must negotiate multiple formularies and tender calendars. Class III-IV cardiac implants undergo extended SFDA documentation, and local language labeling adds translation steps. Despite mutual-recognition provisions with the United States and European Union, average time-to-market extends 8-14 months beyond centralized systems. Suppliers are adding field-based regulatory teams and bilingual digital submission tools to compress review cycles, yet smaller innovators still face cash-flow strain during approval wait times.
Other drivers and restraints analyzed in the detailed report include:
Mandatory private insurance / Localization of manufacturing / Shortage of cardiac electrophysiologists /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Therapeutic & surgical systems generated USD 338.5 billion in 2024, equal to 64.20% of the Saudi Arabia cardiovascular devices market. Stents, grafts, and balloon catheters dominate value, supported by steady cath-lab throughput for coronary revascularization. Drug-eluting stents outpace bare-metal alternatives because of lower restenosis risk and falling unit prices through group purchasing. Hospitals rely on multivessel PCI kits with integrated imaging probes that shorten case times. New procedural guidelines recommending fractional flow reserve assessment for borderline lesions further enlarge accessory sales. Over the outlook, hybrid operating rooms will foster cross-disciplinary adoption of valve-in-valve and thoracic aortic stent-grafting platforms.
Diagnostic & monitoring devices reached USD 118.8 billion in 2024 and will chart the highest 5.93% CAGR. Growing uptake of single-patient ECG patches and Bluetooth blood-pressure cuffs fits Vision 2030 goals for decentralized chronic-disease control. Integrated cloud dashboards that aggregate vital signs are gaining reimbursement codes under private insurance. AI-enabled handheld ultrasounds allow frontline physicians to identify ventricular dysfunction without referral delays. International suppliers partner with telehealth hubs to feed anonymized rhythm and hemodynamic data into national registries, which in turn guide value-based purchasing decisions. The Saudi Arabia cardiovascular devices market size attributable to diagnostics is therefore set to close part of the historical gap with interventional tools.
The Saudi Arabia Cardiovascular Devices Market is Segmented by by Device Type (Diagnostic and Monitoring Devices and Therapeutic and Surgical Devices), by Application (Coronary Artery Disease, Arrhythmia and More), by End User (Hospitals & Cardiac Centers, Ambulatory Surgical Centers and More) and Geography. The Report Offers the Value (in USD) for all the Above.
List of Companies Covered in this Report:
Medtronic / Abbott Laboratories / Boston Scientific / Edward Lifesciences / Terumo / GE HealthCare Technologies Inc. / Koninklijke Philips / Siemens Healthineers / Johnson & Johnson (Mentor/Cordis/Biosense Webster) / BIOTRONIK / Getinge AB (Maquet) / Cook Group / W. L. Gore & Associates / MicroPort / Lepu Medical / B. Braun / LivaNova / Meril Life Science /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Burden of Cardiovascular Diseases in Saudi Arabia
4.2.2 Large?scale Government Investments under Saudi Vision 2030 in Cardiac Care Infrastructure
4.2.3 Mandatory Private-Sector Health Insurance Boosting Procedure Volumes
4.2.4 Localization Initiatives Favouring In-Kingdom Medical-Device Manufacturing
4.2.5 Growing Medical?Tourism Inflow for Complex Cardiac Interventions
4.2.6 Rapid Uptake of Transcatheter Therapies Driven by Hybrid Cath-Lab Expansion
4.3 Market Restraints
4.3.1 Fragmented Hospital Procurement & Lengthy SFDA Approval Cycles
4.3.2 Shortage of Cardiac Electrophysiologists
4.3.3 High Price Sensitivity among Public Hospitals Limiting ASPs
4.3.4 Cultural Barriers Delaying Early Diagnosis in Women
4.4 Value / Supply-Chain Analysis
4.5 Regulatory Outlook
4.6 Technological Outlook
4.7 Porter's Five Forces
4.7.1 Bargaining Power of Suppliers
4.7.2 Bargaining Power of Buyers
4.7.3 Threat of New Entrants
4.7.4 Threat of Substitutes
4.7.5 Competitive Rivalry
5 Market Size & Growth Forecasts (Value)
5.1 By Device Type
5.1.1 Diagnostic & Monitoring Devices
5.1.1.1 ECG Systems
5.1.1.2 Remote Cardiac Monitor
5.1.1.3 Cardiac MRI
5.1.1.4 Cardiac CT
5.1.1.5 Echocardiography / Ultrasound
5.1.1.6 Fractional Flow Reserve (FFR) Systems
5.1.2 Therapeutic & Surgical Devices
5.1.2.1 Coronary Stents
5.1.2.1.1 Drug-Eluting Stents
5.1.2.1.2 Bare-Metal Stents
5.1.2.1.3 Bioresorbable Stents
5.1.2.2 Catheters
5.1.2.2.1 PTCA Balloon Catheters
5.1.2.2.2 IVUS/OCT Catheters
5.1.2.3 Cardiac Rhythm Management
5.1.2.3.1 Pacemakers
5.1.2.3.2 Implantable Cardioverter Defibrillators
5.1.2.3.3 Cardiac Resynchronization Therapy Devices
5.1.2.4 Heart Valves
5.1.2.4.1 TAVR/TAVI
5.1.2.4.2 Mechanical Valves
5.1.2.4.3 Tissue/Bioprosthetic Valves
5.1.2.5 Ventricular Assist Devices
5.1.2.6 Artificial Hearts
5.1.2.7 Grafts & Patches
5.1.2.8 Other Cardiovascular Surgical Devices
5.2 By Application
5.2.1 Coronary Artery Disease
5.2.2 Arrhythmia
5.2.3 Heart Failure
5.2.4 Structural Heart Disease
5.2.5 Hypertension
5.2.6 Others
5.3 By End-User
5.3.1 Hospitals
5.3.2 Home-Care Settings
5.3.3 Others
6 Competitive Landscape
6.1 Market Concentration
6.2 Strategic Moves
6.3 Market Share Analysis
6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
6.4.1 Medtronic plc
6.4.2 Abbott Laboratories
6.4.3 Boston Scientific Corporation
6.4.4 Edwards Lifesciences Corporation
6.4.5 Terumo Corporation
6.4.6 GE HealthCare Technologies Inc.
6.4.7 Philips Healthcare
6.4.8 Siemens Healthineers AG
6.4.9 Johnson & Johnson (Mentor/Cordis/Biosense Webster)
6.4.10 Biotronik SE & Co. KG
6.4.11 Getinge AB (Maquet)
6.4.12 Cook Medical LLC
6.4.13 W. L. Gore & Associates
6.4.14 MicroPort Scientific Corporation
6.4.15 Lepu Medical Technology
6.4.16 B. Braun Melsungen AG
6.4.17 LivaNova PLC
6.4.18 Meril Life Sciences Pvt Ltd
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-Need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security